ZACKS
Search documents
HDLMY vs. ROAD: Which Stock Should Value Investors Buy Now?
ZACKS· 2026-02-18 17:41
Core Viewpoint - Investors are evaluating Heidelberg Materials AG Unsponsored ADR (HDLMY) and Construction Partners (ROAD) for potential undervalued stock opportunities in the Building Products - Miscellaneous sector [1] Valuation Metrics - Both HDLMY and ROAD currently hold a Zacks Rank of 2 (Buy), indicating positive earnings estimate revisions and improving earnings outlooks [3] - HDLMY has a forward P/E ratio of 13.53, significantly lower than ROAD's forward P/E of 47.68, suggesting HDLMY may be undervalued [5] - The PEG ratio for HDLMY is 0.93, while ROAD's PEG ratio is 1.26, indicating that HDLMY has a more favorable earnings growth outlook relative to its valuation [5] - HDLMY's P/B ratio is 2.1, compared to ROAD's P/B of 7.8, further supporting the notion that HDLMY is undervalued [6] - Based on these valuation metrics, HDLMY is rated with a Value grade of B, while ROAD has a Value grade of D, indicating a stronger value proposition for HDLMY [6][7]
STRT or ATMU: Which Is the Better Value Stock Right Now?
ZACKS· 2026-02-18 17:40
Investors interested in stocks from the Automotive - Original Equipment sector have probably already heard of Strattec Security (STRT) and Atmus Filtration Technologies (ATMU) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision t ...
NEXA or TECK: Which Is the Better Value Stock Right Now?
ZACKS· 2026-02-18 17:40
Core Viewpoint - Investors in the Mining - Miscellaneous sector should consider Nexa Resources S.A. (NEXA) and Teck Resources Ltd (TECK) for potential undervalued stock opportunities [1] Group 1: Zacks Rank and Earnings Outlook - Nexa Resources S.A. has a Zacks Rank of 1 (Strong Buy), indicating a favorable earnings outlook, while Teck Resources Ltd has a Zacks Rank of 3 (Hold) [3] - The Zacks Rank emphasizes stocks with positive revisions to earnings estimates, suggesting that NEXA has an improving earnings outlook [3] Group 2: Valuation Metrics - Nexa Resources has a forward P/E ratio of 7.52, significantly lower than Teck Resources' forward P/E of 27.26 [5] - NEXA's PEG ratio is 0.21, compared to TECK's PEG ratio of 0.54, indicating NEXA may be undervalued relative to its expected EPS growth [5] - NEXA's P/B ratio is 1.18, while TECK's P/B ratio is 1.48, further supporting NEXA's valuation advantage [6] Group 3: Value Grades - NEXA has earned a Value grade of B, while TECK has a Value grade of D, highlighting NEXA's stronger position in terms of value metrics [6] - The combination of Zacks Rank and Style Scores indicates that NEXA is the preferred option for value investors at this time [6]
CTS vs. OSIS: Which Stock Is the Better Value Option?
ZACKS· 2026-02-18 17:40
Core Viewpoint - Investors in the Electronics - Miscellaneous Components sector should consider CTS and OSI Systems as potential undervalued stocks, with CTS currently appearing to be the superior option based on various valuation metrics and earnings estimate revisions [1]. Valuation Metrics - CTS has a forward P/E ratio of 23.24, while OSI Systems has a forward P/E of 25.30, indicating that CTS may be more attractively priced relative to its earnings [5]. - The PEG ratio for CTS is 1.45, compared to OSI Systems' PEG ratio of 2.16, suggesting that CTS offers better value when considering expected earnings growth [5]. - CTS has a P/B ratio of 2.95, while OSI Systems has a P/B of 5.15, further supporting the notion that CTS is undervalued relative to its book value [6]. Analyst Outlook - CTS holds a Zacks Rank of 2 (Buy), indicating a more favorable earnings estimate revision trend compared to OSI Systems, which has a Zacks Rank of 3 (Hold) [3]. - The stronger estimate revision activity for CTS suggests an improving analyst outlook, making it a more attractive option for value investors [7].
BGC vs. EVR: Which Stock Is the Better Value Option?
ZACKS· 2026-02-18 17:40
Core Viewpoint - BGC Group (BGC) is currently viewed as a superior value option compared to Evercore (EVR) based on various valuation metrics [7] Valuation Metrics - BGC has a forward P/E ratio of 6.80, while EVR has a forward P/E of 17.28 [5] - BGC's PEG ratio is 0.34, indicating a more favorable valuation in relation to its expected EPS growth compared to EVR's PEG ratio of 0.51 [5] - BGC's P/B ratio stands at 3.91, compared to EVR's P/B of 5.93, suggesting BGC is more undervalued relative to its book value [6] Earnings Outlook - Both BGC and EVR hold a Zacks Rank of 2 (Buy), indicating positive earnings estimate revisions and an improving earnings outlook for both companies [3]
FDA Accepts BMY's NDA for Iberdomide Combo in Multiple Myeloma
ZACKS· 2026-02-18 17:36
Core Insights - Bristol Myers Squibb (BMY) has received FDA acceptance for the new drug application (NDA) of iberdomide, in combination with daratumumab and dexamethasone, for treating relapsed or refractory multiple myeloma (RRMM) [1][7] - The FDA has granted a priority review for the NDA, with a decision expected on August 17, 2026 [1] - Iberdomide is part of a new class of drugs known as cereblon E3 ligase modulators (CELMoDs), which are under investigation for RRMM treatment [2][8] BMY's Price Performance - Over the past six months, BMY shares have increased by 24.8%, outperforming the industry average rise of 21.4% [3] Iberdomide Development - The NDA filing is based on data from the phase III EXCALIBER-RRMM study, which showed a statistically significant improvement in minimal residual disease (MRD) negativity rates compared to the control arm [4][7] - The study is ongoing, with patients being assessed for progression-free survival [5] Regulatory Designations - Iberdomide has received Breakthrough Therapy designation from the FDA for the treatment of RRMM [2][7] - The review process is part of the FDA's Project Orbis initiative, allowing simultaneous evaluation by regulatory authorities in other countries [8] Strategic Focus - The successful development of iberdomide and other key pipeline candidates is crucial for Bristol Myers as it aims to expand and diversify its portfolio amid challenges from generic competition [9]
Is Chegg's $40B Skilling Market Bet a True Turnaround Catalyst?
ZACKS· 2026-02-18 17:36
Core Insights - Chegg, Inc. is making a significant strategic shift towards the $40 billion global workforce skilling market, splitting its operations into Chegg Skilling for growth and Academic Services for cash flow generation [1] Group 1: Financial Performance - Chegg Skilling revenues increased by 11% year over year in Q4 2025, reaching $17.7 million, while overall revenues declined by 39% year over year in 2025 and 49% in Q4 [2][3] - The company expects to generate meaningful free cash flow in 2026 despite incurring near-term severance expenses, ending the quarter with $85 million in cash and investments [2] Group 2: Market Position and Competition - Chegg is transitioning from academic support services to focus on B2B skilling, competing with platforms like Coursera and Udemy, which have established niches in academic credibility and broad course offerings respectively [4][5][6] - Chegg's transformation is marked by a deeper integration of AI to provide personalized, skills-based learning rather than just academic support [6] Group 3: Stock Performance and Valuation - Chegg's stock has decreased by 45.4% over the past three months, underperforming compared to the Zacks Internet - Software industry, the Zacks Computer and Technology sector, and the S&P 500 Index [7] - The stock is currently trading at a forward 12-month price-to-sales (P/S) ratio of 0.24, indicating a discount compared to industry peers [9] Group 4: Earnings Estimates - The Zacks Consensus Estimate for Chegg's 2026 bottom line has widened to a loss of 11 cents per share, reflecting a 466.7% year-over-year decline [11]
UK Equity ETF (FLGB) Hits New 52-Week High
ZACKS· 2026-02-18 17:36
Core Viewpoint - Franklin FTSE United Kingdom ETF (FLGB) has reached a 52-week high, increasing by 44.54% from its 52-week low of $25.10 per share, indicating strong momentum and potential for further gains [1] Group 1: ETF Overview - FLGB tracks the FTSE UK RIC Capped Index, which is a market-capitalization weighted index representing UK large and mid-cap stocks [2] - The ETF charges an annual fee of 0.09% [2] Group 2: Market Drivers - The FTSE 100, the UK's benchmark index, has reached a record high due to softer domestic inflation data, which has raised expectations for potential interest rate cuts by the Bank of England as early as March [3] Group 3: Performance Outlook - FLGB holds a Zacks ETF Rank of 3 (Hold) and has a positive weighted alpha of 30.89, suggesting the possibility of continued strong performance in the near term [4]
Staying Invested, Diversified and Ahead With ETFs
ZACKS· 2026-02-18 17:36
Market Overview - The S&P 500 experienced a decline of approximately 1.3% last week due to AI-related volatility, but showed signs of stabilization with a 0.14% increase on Tuesday [1] - The concentration of the S&P 500 in the information technology sector is about 33%, highlighting concentration risk amid rising anxiety around AI disruption [4] Investor Sentiment - A record share of investors, approximately 35%, believe companies are overspending on AI, marking the largest concern in over two decades [2] - About 25% of investors view an "AI bubble" as a primary tail risk, while 30% cite aggressive AI capital expenditure by large tech firms as a leading credit risk [3] Diversification Strategies - Diversification is essential not only to mitigate technology exposure but also due to broader structural risks such as high U.S. national debt and complex geopolitical issues [5] - ETFs are recommended for diversification, providing benefits like tax efficiency and a disciplined investment approach [6][11] Investment Approaches - A buy-and-hold strategy is suggested for sustainable long-term returns, helping investors avoid emotional decision-making during market fluctuations [8] - Equal-weighted index funds, such as the S&P 500 Equal Weight Index, have gained 11.76% over the past year and 5.50% year-to-date, offering sector-level diversification [9] ETF Recommendations - Invesco S&P 500 Equal Weight ETF (RSP) has a 60.96% allocation to equities and a dividend yield of 2.47% [10][12] - iShares Core 80/20 Aggressive Allocation ETF (AOA) has 80.44% in equities and a dividend yield of 2.10% [12] - iShares Core 30/70 Conservative Allocation ETF (AOK) has 30.94% in equities and a dividend yield of 3.25% [13] - Multi-Asset Diversified Income Index Fund (MDIV) charges an annual fee of 0.75% and has a dividend yield of 6.10%, with significant exposure to dividend-paying equities and other asset classes [14]
Can Commercial Metals' TAG Program Drive Margin Expansion?
ZACKS· 2026-02-18 17:36
Core Insights - Commercial Metals Company's (CMC) Transform, Advance, Grow (TAG) Program aims to enhance margins, earnings, cash flows, and return on invested capital (ROIC), with an expected annualized EBITDA benefit of $150 million by fiscal 2026 [1][8] Group 1: TAG Program Overview - Launched in 2024, the TAG program focuses on optimizing logistics, reducing input consumption, lowering costs, and improving energy efficiency through over 150 individual projects across all business segments [2] - The program has already led to improvements in melt shops and rolling mills, resulting in higher product volumes while maintaining energy and raw material consumption levels [2] - CMC anticipates significant and lasting transformation in its margin profile from the TAG program, alongside strong market dynamics and effective operational execution [4] Group 2: Performance and Market Position - CMC has experienced success in optimizing scrap, improving yield, and cost mix, maintaining solid momentum in the TAG program during the first fiscal quarter [3] - CMC shares have increased by 51.3% over the past year, outperforming the industry growth of 50.1% and the Zacks Basic Materials sector's return of 47.2% [7] - The Zacks Consensus Estimate for CMC's fiscal 2026 sales is projected at $8.89 billion, reflecting a 13.9% year-over-year increase, with earnings expected to rise by 134.5% to $7.34 per share [11] Group 3: Competitive Landscape - Cleveland-Cliffs Inc. is implementing cost-reduction initiatives, targeting a decrease in steel unit costs by $150 per ton over three years, while Steel Dynamics, Inc. is developing a lower-carbon facility to enhance its product portfolio [5][6] - CMC is currently trading at a forward price/sales ratio of 0.96, compared to the industry's 1.77, indicating a favorable valuation [10]